Scientists at UC San Francisco have discovered a new way to target and shrink pancreatic cancer in mice by combining a high-fat ketogenic diet with a...
Vous n'êtes pas connecté
Researchers from the University of Massachusetts Amherst and UMass Chan Medical School have made a significant breakthrough in treating pancreatic cancer. Their study, published in Science Translational Medicine, describes a new method that successfully shrinks and even clears tumors in mice. This innovative approach combines a novel drug-delivery system with immune-boosting agents to target and […]
Scientists at UC San Francisco have discovered a new way to target and shrink pancreatic cancer in mice by combining a high-fat ketogenic diet with a...
Using a new workflow that integrates spatial transcriptomics and machine learning for imaging analysis and integration with single-cell datasets,...
WashU Medicine researchers have designed, in mice, an approach to minimizing the damage from a spinal cord injury through the use of engineered immune...
WashU Medicine researchers have designed, in mice, an approach to minimizing the damage from a spinal cord injury through the use of engineered immune...
RNA nasal spray: A groundbreaking innovation in treating memory loss and anxiety, offering new hope for more effective and non-invasive therapies.
Breakthrough in triple-negative breast cancer diagnosis: New test improves early detection, offering better outcomes and personalized treatment...
VANCOUVER, British Columbia & NEW YORK — Integrated Nanotherapeutics (INT), a biotechnology company developing innovative treatments for...
VANCOUVER, British Columbia & NEW YORK — Integrated Nanotherapeutics (INT), a biotechnology company developing innovative treatments for...
Scientists are on the verge of a cancer breakthrough after working out how the body’s immune system targets cells devastated by the disease. A new...
A recent study by Ludwig Cancer Research has uncovered a crucial metabolic switch in the immune system’s T cells that plays a vital role in creating...